Ambicom (ABHI) 10-Q/A 5 Jan 15 2015 Q1 Quarterly report (amended) Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Oct. 31, 2014	Dec. 22, 2014
Document Information [Line Items]
Entity Registrant Name	AMBICOM HOLDINGS, INC
Entity Central Index Key	1444310
Current Fiscal Year End Date	-24
Entity Filer Category	Smaller Reporting Company
Trading Symbol	ABHI
Entity Common Stock, Shares Outstanding		48,505,617
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Oct-14
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2015

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Oct. 31, 2014	Jul. 31, 2014
Current assets:
Cash and cash equivalents	$194,345	$523,540
Accounts receivable, net of allowance for doubtful accounts of $166 and $26 as of October 31, 2014, and July 31, 2014, respectively	1,482	490
Inventory, net of reserve balances of $6,361 and $7,352 as of October 31, 2014, and July 31, 2014, respectively	57,733	64,120
Prepaid expenses and other current assets	36,012	9,839
Total current assets	289,572	597,989
Property and equipment, net	91,142	97,563
Deposit	20,695	20,695
Intangible assets, net	4,895,226	5,082,375
Total assets	5,296,635	5,798,622
Current liabilities:
Accounts payable and accrued liabilities	211,343	143,105
Deferred revenue	1,980	1,980
Note payable (Auto Loan) - current portion	15,688	15,735
Total current liabilities	229,011	160,820
Note payable (Auto Loan), net of current portion	55,716	58,978
Total liabilities	284,727	219,798
Commitment and contingency (Note 5)
Stockholders' equity:
Common stock, $0.008 par value; 125,000,000 shares authorized; 27,542,528 and 26,162,093 shares issued and outstanding at October 31, 2014 and July 31, 2014	220,338	209,294
Additional paid in capital	16,853,492	16,517,451
Accumulated deficit	-12,334,397	-11,420,396
Total stockholders’ equity	4,749,433	5,316,349
Total liabilities and stockholders' equity	5,296,635	5,798,622
Series A Preferred Stock [Member]
Stockholders' equity:
Preferred stock, Series A, $0.001 par value; 10,000,000 shares authorized; 10,000,000 shares issued and outstanding at October 31, 2014 and July 31, 2014	10,000	10,000
Redeemable Convertible Preferred Stock [Member]
Current liabilities:
Convertible redeemable preferred stock, Series B, $0.008 par value 325,000 shares authorized; 262,475 shares issued and outstanding at October 31, 2014 and July 31, 2014. (Liquidation preference $2,600,000) - (Note 10)	$262,475	$262,475

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Oct. 31, 2014	Jul. 31, 2014
Allowance for doubtful accounts (in dollars)	$166	$26
Inventory valuation reserve (in dollars)	6,361	7,352
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	27,542,528	26,162,093
Common stock, shares outstanding	27,542,528	26,162,093
Series A Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	10,000,000	10,000,000
Preferred stock, shares outstanding	10,000,000	10,000,000
Redeemable Convertible Preferred Stock [Member]
Temporary Equity, Par or Stated Value Per Share	$0.01	$0.01
Temporary Equity, Shares Authorized	325,000	325,000
Temporary Equity, Shares Issued	262,475	262,475
Temporary Equity, Shares Outstanding	262,475	262,475
Temporary Equity, Liquidation Preference	$2,600,000	$2,600,000

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Sales	$102,755	$799,482
Cost of sales	94,428	395,273
Gross profits	8,327	404,209
Operating Expenses
Selling and general expenses	406,607	215,414
Professional fees	206,180	27,294
Amortization of acquisition-related intangible	187,149	0
Research and development	115,029	32,100
Depreciation	6,421	4,134
Total operating expenses	921,386	278,942
Income (Loss) from operations	-913,059	125,267
Other income (expense)
Interest expense, net	-942	-286
Total income (loss) before income taxes	-914,001	124,981
Income taxes	0	1,600
Net income (loss)	($914,001)	$123,381
Net income (loss) per share - basic (in dollars per share)	($0.03)	$0.01
Net income (loss) per share - diluted (in dollars per share)	($0.03)	$0.01
Weighted average shares outstanding - basic (in shares)	26,958,436	10,814,853
Weighted average shares outstanding - diluted (in shares)	26,958,436	18,127,328

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Cash flows from operating activities:
Net income (loss)	($914,001)	$123,381
Adjustment to reconcile net income (loss) to net cash used in operating activities:
Amortization of intangible	187,149	0
Stock based compensation	63,384	1,560
Depreciation	6,421	4,134
Change in bad debt reserve	140	0
Change in inventory reserve	-991	101
Decrease/ (increase) in operating assets and liabilities:
Accounts receivable	-1,132	191,861
Inventory	7,376	640
Prepaid expenses and other current assets	-26,173	25,884
Accounts payable and accrued liabilities	68,238	-13,178
Deferred revenue	0	-380,000
Net cash used in operating activities	-425,889	-38,617
Cash flows from investing activities:
Capital expenditures	0	-105,279
Net cash used in investing activities	0	-105,279
Cash flows from financing activities:
Proceeds from sale of common stock	100,000	0
Proceeds from note payable	0	85,278
Payments on note payable	-3,306	-1,048
Net cash provided by financing activities	96,694	84,230
Net decrease in cash and cash equivalents	-329,195	-59,666
Cash and cash equivalents, beginning of period	523,540	596,871
Cash and cash equivalents, end of period	194,345	537,205
Supplemental information:
Income taxes paid	0	0
Interest paid	942	286
Advisors [Member]
Adjustment to reconcile net income (loss) to net cash used in operating activities:
Issuance of stock	106,200	7,000
Investor Relations Firm [Member]
Adjustment to reconcile net income (loss) to net cash used in operating activities:
Issuance of stock	$77,500	$0

Organization_and_Principal_Act

Organization and Principal Activities	3 Months Ended
	Oct. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations [Text Block]	Note 1 – Organization and Principal Activities
	AmbiCom Holdings, Inc. (“AmbiCom Holdings” or the ‘Company”) was incorporated as Med Control, Inc. (“Med Control”) under the laws of the State of Nevada on July 1, 2008. Med Control was a development stage enterprise until January 15, 2010. All of Med Control’s activities prior to January 15, 2010 related to its organization, initial funding and share issuances.
	On January 15, 2010, the Company authorized an amendment its Articles of Incorporation (the “Amendment”) to change its name to AmbiCom Holdings, Inc., to increase the number of its authorized shares of capital stock from 75,000,000 to 1,050,000,000 shares of which 1,000,000,000 were designated common stock, par value $0.001 per share (the “Common Stock”) and 50,000,000 were designated preferred stock, par value $0.001 per share (the “Preferred Stock”) and to effect a forward-split such that 131.2335958 shares of Common Stock were issued for every 1 share of Common Stock issued and outstanding immediately prior to filing of the amendment (the “Forward Split”).
	Also on January 15, 2010, the Company acquired AmbiCom Acquisition Corp. a privately owned Nevada corporation (“AmbiCom”), pursuant to an Agreement and Plan of Share Exchange (the “Exchange”). AmbiCom was organized under the laws of the State of Nevada on July 29, 2008. AmbiCom Holdings is a holding company whose operating company, AmbiCom, Inc., is a designer and developer of wireless products focusing on the wireless medical industry. AmbiCom’s wireless modules and devices are based on its innovative application software and Wi-Fi or Bluetooth technologies.
	Pursuant to the terms of the Exchange, the Company acquired AmbiCom from the AmbiCom former equity holders in exchange for an aggregate of 20,000,000 newly issued shares of Common Stock, 2,600,000 shares of Series B Preferred Stock, an option to purchase 5,500,000 shares of Common Stock and 2,350,000 shares of Series A Preferred Stock at the purchase price of $0.01 per share, and warrants to purchase 500,000 shares of Common Stock at the exercise price of $0.50 per share (collectively, the “Exchange Shares”). As a result of the Exchange, the AmbiCom equity holders surrendered all of their issued and outstanding capital stock of AmbiCom in consideration for the Exchange Shares and AmbiCom became a wholly-owned subsidiary of the Company.
	Simultaneously upon the Closing, the Company closed an offering (the “Offering”) of its Common Stock at a price of $0.40 per share for an aggregate of 1,250,000 shares of Common Stock for aggregate offering price of $500,000.
	For financial accounting purposes, the acquisition was a reverse acquisition of the Company by AmbiCom, under the purchase method of accounting, and was treated as a recapitalization with AmbiCom as the acquirer.  Upon consummation of the Exchange, the Company adopted the business plan of AmbiCom.
	On May 29, 2014, the Company acquired all of the assets of Veloxum Corporation, a Delaware corporation (“Veloxum”) in consideration for the issuance of 13,100,437 shares of the Company’s Common Stock. Following the Company’s acquisition of all of Veloxum’s assets, the Company has focused its operations as an optimizer of server’s infrastructure configuration settings.
	Details of the Company’s subsidiary as of October 31, 2014 are as follows:
	Name	Place and Date of	Relationships	Principal Activities
		Establishment/
		Incorporation
	E-Care USA, Inc.	Nevada	Wholly-owned subsidiary of AmbiCom Holdings, Inc.	Designer and developer of wireless home medical devices
		15-Mar-11
	Inter-company accounts and transactions have been eliminated in consolidation.

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Oct. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting [Text Block]	Note 2 – Basis of Presentation
	The accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The condensed balance sheet at July 31, 2014 has been derived from the audited financial statements at that date, but does not include all disclosures, including notes, required by GAAP for complete financial statements. In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the periods presented.
	The unaudited interim condensed financial statements have been prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments of a normal recurring nature considered necessary to present fairly its financial position as of October 31, 2014 and results of its operations and cash flows for the three months ended October 31, 2014 and 2013. The interim results are not necessarily indicative of the results for any future interim period or for the entire year. Certain prior period amounts have been reclassified to conform to current period presentation. The accompanying condensed financial statements and related financial information should be read in conjunction with the audited financial statements and the related notes thereto for the year ended July 31, 2014 included in the Company’s Form 10-K.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Oct. 31, 2014
Accounting Policies [Abstract]
Business Description and Accounting Policies [Text Block]	Note 3 – Summary of Significant Accounting Policies
	The summary of significant accounting policies is presented to assist in understanding the Company’s financial statements. These accounting policies conform to generally accepted accounting principles and have been consistently applied in the preparation of the financial statements.
	a) Segment Information - The Company follows ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information.” Topic 280 requires that a company report financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker currently evaluates the Company’s operations from a number of different operational perspectives including but not limited to a client by client basis. The Company derives all significant revenues from a single reportable operating segment of business. Accordingly, the Company does not report more than one segment; nevertheless, management evaluates, at least annually, whether the Company continues to have one single reportable segment.
	b) Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates, and the differences may be material to the financial statements. Estimates are used primarily in determining the depreciable lives of fixed assets, valuation of stock based compensation, and inventory valuation. In addition, estimates form the basis for the reserves for sales allowances, accounts receivable and inventory. Various assumptions go into the determination of these estimates. The process of determining significant estimates requires consideration of factors such as historical experience and current and expected economic conditions.
	c) Cash and Cash Equivalents - The Company considers all highly liquid investments and time deposits with original maturities of three months or less when purchased to be cash equivalents. All cash and cash equivalents are maintained with nationally recognized financial institutions.
	d) Allowance for Doubtful Accounts - An allowance for doubtful accounts is computed based on the Company’s historical experience and management’s analysis of possible bad debts. Accounts receivable are shown net of an allowance for doubtful accounts of $166as of October 31, 2014 and $26 as of July 31, 2014, respectively.
	e) Inventory - Inventory is stated at the lower of cost or market on an average cost basis. Inventory reserves are recorded for damaged, obsolete, excess and slow-moving inventory. Market value of inventory is estimated based on the impact of market trends, an evaluation of economic conditions and the value of current orders relating to the future sales of this type of inventory. As of October 31, 2014 and July 31, 2014, the value of the inventory reserve was $6,361 and $7,352 respectively, and the majority of the inventory was comprised of finished goods.
	f) Income Taxes - The Company accounts for income taxes pursuant to the FASB ASC Topic 740, "Accounting for Uncertainty in Income Taxes", (“Topic 740”). Topic 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements in accordance with generally accepted accounting principles. The calculation of the Company's tax provision involves the application of complex tax rules and regulations within multiple jurisdictions. The Company's tax liabilities include estimates for all income-related taxes that the Company believes are probable and that can be reasonably estimated. To the extent that the Company’s estimates are understated, additional charges to the provision for income taxes would be recorded in the period in which the Company determines such understatement. If the Company's income tax estimates are overstated, income tax benefits will be recognized when realized. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Topic 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
	g) Intangible Assets – Developed technology and trade names were acquired as part of the Veloxum transaction in May 2014. Acquisition –related intangibles are amortized over their estimated useful lives based on expected future benefit.
	The carrying amounts of the intangible assets as of October 31, 2014 and July 31, 2014 are as follows:
		Intangible Assets, Gross						Accumulated Amortization						Intangible Assets, Net				Weighted
																		Average Useful
																		Life
		July 31, 2014		Additions		31-Oct-14		31-Jul-14		Expense		October 31, 2014		31-Jul-14		October 31, 2014		(Years)
	Developed technology	$	4,423,375	$	-	$	4,423,375	$	-133,203	$	-157,978	$	-291,181	$	4,290,172	$	4,132,194		7
	Trade names		816,800				816,800		-24,597		-29,171		-53,768		792,203		763,032		7
	Total intangible assets, net	$	5,240,175	$	-	$	5,240,175	$	-157,800	$	-187,149	$	-344,949	$	5,082,375	$	4,895,226
	Total amortization expense related to intangible assets was $187,149 for the three months ended October 31, 2014, all of which was recorded in operating expenses. As of October 31, 2014, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows:
						Total
		Developed		Trade		intangible
	Year ending July 31,	technology		names		assets
	2015	$	473,933	$	87,515	$	561,448
	2016		631,911		116,686		748,597
	2017		631,911		116,686		748,597
	2018		631,911		116,686		748,597
	2019		631,911		116,686		748,597
	Thereafter		1,130,617		208,773		1,339,390
	Total intangible assets subject to amortization		4,132,194	$	763,032	$	4,895,226
	Developed technology and trade name are tested for impairment based on the guidelines in Accounting Standards Codification Topic 360-10-35, Impairment or Disposal of Long-Lived Assets
	A long-lived asset or asset group that is held and used should be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount for the long-live asset or asset group might not be recoverable. As a result, a company is not required to perform an impairment analysis if indicators of impairment are not present. Instead, a company would assess the need for an impairment write-down only if an indicator of impairment (also referred to as a triggering event) is present. As of October 31, 2014, no triggering events have occurred which would indicate that the acquired Veloxum developed technology and trade name values may not be recoverable. The strategy and plans that had been put in place at the original acquisition date were still effective and progressing as planned.
	h) Revenue Recognition - The Company's product revenues are recognized upon shipment or delivery and acceptance of products by customers, when pervasive evidence of a sales arrangement exists, the price is fixed or determinable, the title has transferred and collection of resulting receivables is reasonably assured. For service and development projects, the company recognizes revenue upon the completion of the service and records costs incurred by the company for service and development under the project as cost of sales expenses.
	i) Research and Development Costs -Research and development costs are charged to operations as incurred. Research and development expenses consist primarily of compensation and related costs for personnel responsible for the research and development activities relating to new and existing products.
	j) Stock-Based Compensation - The Company accounts for its stock-based compensation expense based on the fair value of the stock-based awards that are ultimately expected to vest. The fair value of employee stock option grant is estimated on the date of grant using the Black-Scholes option pricing model, and is recognized as expense on a straight-line basis over the employee’s requisite service period (generally the vesting period), net of estimated forfeitures. Forfeitures are estimated at the time of grant and revised in subsequent periods if actual forfeitures differ from the prior estimates.
	The Company records the expense attributed to non-employee services paid with stock-based awards based on the estimated fair value of the awards determined using the Black-Scholes option pricing model. The measurement of stock-based compensation for non-employees is subject to re-measurement as the options vest, and the expense is recognized over the period during which services are received.
	k) Fair Value of Financial Instruments -  The Company records its financial assets and liabilities at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value should maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting guidance for fair value establishes a three-level hierarchy for disclosure of fair value measurements, as follows:
	Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.
	Level 2—Inputs (other than quoted market prices included in Level 1) that are either directly or indirectly observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the instrument’s anticipated life.
	Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The carrying values of certain financial assets and liabilities of the Company, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities. The carrying value of the Company’s note payable (Auto loan) approximates its fair value as the terms of the borrowing are consistent with current market rates that the Company could obtain for debt with similar terms and maturities.
	l) Concentration - Financial instruments which potentially subject the Company to concentrations of credit risk are primarily accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition. If the collection of the receivable becomes doubtful, the Company establishes a reserve in an amount determined appropriate for the perceived risk.
	The Company maintains its cash accounts at commercial banks. From time to time, cash balances maintained in such banks may exceed the insured amount by the Federal Deposit Insurance Corporation (FDIC). As of October 31, 2014 and July 31, 2014, management does not believe they are exposed to any significant risk on their cash balances. The Company’s products are primarily sold to global medical device companies. These customers can be significantly affected by changes in economic, competitive or other factors. The Company makes substantial sales to a relatively few, large customers, where company is seeking to capture more business from other targeted medical device companies.
	One customer accounted for $85% of revenue for the three months ended October 31, 2014 and two customers accounted for 92% of revenue for the three months ended October 31, 2013.
	One vendor accounted for 100% of the purchases for the three months ended October 31, 2014, and one vendor accounted for 97% of the purchases for the three months ended October 31, 2013.

Liquidity_and_Managements_Plan

Liquidity and Management's Plan	3 Months Ended
	Oct. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity and Managements Plan [Text Block]	Note 4 -Liquidity and Management’s Plan
	As of October 31, 2014, the Company had cash and cash equivalents of $194,345 and an accumulated deficit of $12,334,397. The Company also incurred a net loss of $914,001 and had net cash used in operating activities of $425,889 for the three months ended October 31, 2014. Given the Company’s negative cash flow from operations management anticipated its cash constraints and, therefore, took measures to meet its obligations. On December 18, 2014, the Company effectuated a Securities Purchase Agreement with an accredited investor for the purchase and sale of up to $285,000 of the Company’s original issue discount convertible debentures. The first Debenture, in the principal amount of $160,000, was issued on December 18, 2014 (Note 11- Subsequent Events). Additionally, the Company has access to an equity investment line pursuant to the investment agreement with Kodiak Capital Group, LLC. The investment agreement provides for common stock investments in the Company in increments of $25,000 up to a total investment balance of $1 million, of which $175,000 have already been invested. Management expects its new business for automated optimization of software applications will start generating revenue in the quarter ending January 31, 2015 and continue to grow. There can be no assurances that management will be able to successfully implement a long-term solution, and accordingly, the Company continues to explore debt and equity financing options.
	The Company believes in the viability of its strategy to increase revenue, cash flows, and profitability and in its ability to raise additional funds, and believes that the actions presently being taken by the Company will provide the Company with sufficient liquidity to continue to finance its operations and continue as a going concern.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Oct. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 5 –Commitments and Contingencies
	The Company leases its office and warehouse. The maturity date for the lease is May 2016. Rent expense was $13,419 for the three months ended October 31, 2014 and for the three months ended October 31, 2013.

Series_B_Convertible_Redeemabl

Series B Convertible Redeemable Preferred Stock	3 Months Ended
	Oct. 31, 2014
Equity [Abstract]
Convertible Redeemable Preferred Stock, Series B [Text Block]	Note 6 - Series B Convertible Redeemable Preferred Stock
	In September 2011, the Company amended and restated its Articles of Incorporation. Before the amendment, there were 2,600,000 shares of Series B Convertible Preferred Stock authorized at $0.001 par value per share. After the amendment, the authorized number of shares of Series B Convertible Preferred Stock was changed to  325,000 at $0.008 par value per share.
	As of July 31, 2014, there were 262,475 shares of Series B Convertible Preferred Stock outstanding. During the quarter ended October 31, 2014, there were no changes to the shares of Series B. There are 262,475 shares of Series B outstanding as of October 31, 2014.
	The Series B accrues annual dividends at the rate of 6% per year in shares of Common Stock at the dividend conversion rate of $1.00.  The Series B, together with any unpaid dividends, is convertible at any time into shares of the Company’s common stock at the conversion rate of eight shares of Common Stock for each share of Series B converted.  Following the second anniversary of the Exchange, the Series B, together with any unpaid dividends, shall be convertible into Common Stock at the conversion price divided by the greater of forty cents ($0.40) or seventy percent (70%) of the daily volume weighted average price of the Common Stock for the twenty trading days immediately prior to the conversion.  The Series B is redeemable by the Company, at any time prior to December 31, 2015, in cash at the redemption rate of $1.00 per share of Series B plus any accrued and unpaid dividends.  On December 31, 2015, all outstanding shares of Series B shall be redeemed by the Company at a per share redemption price equal to $1.00 per share of Series B plus an amount of Common Stock equal to the amount of the accrued and unpaid dividend thereon.  The Series B has a liquidation preference of $2,600,000 and has priority over the Series A Preferred Stock and the Common Stock.  The Series B votes on an “as converted” basis.

Shareholders_Equity

Shareholders' Equity	3 Months Ended
	Oct. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 7 – Shareholders’ Equity
	Preferred Stock
	The Company's Amended Articles of Incorporation authorizes the issuance of 50,000,000 shares of Preferred Stock, par value $0.001 per share, subject to any limitations prescribed by law, without further vote or action by the stockholders, to issue from time to time shares of preferred stock in one or more series. Each such series of Preferred Stock shall have such number of shares, designations, preferences, voting powers, qualifications, and special or relative rights or privileges as shall be determined by the Company's board of directors, which may include, among others, dividend rights, voting rights, liquidation preferences, conversion rights and preemptive rights.
	Series A Convertible Preferred Stock
	The Company has authorized a total of 10,000,000 shares of Series A Convertible Preferred Stock (the “Series A”).  The Series A is convertible at any time into shares of the Company’s common stock at the conversion rate of one share of Common Stock per each share of Series A converted.  The Series A is treated on an “as converted” basis for both voting and liquidation rights. In June 2011, an amendment was filed with the Secretary of State of Nevada whereby the conversion price of Series A would remain unchanged in event of stock split, stock dividend on the common stock, a reclassification of the common stock or distribution to holders of common stock. If the Company reports net income in two of the following four years following the Exchange, the Series A shall be convertible into Common Stock at the conversion rate of two shares of Common Stock per each share of Series A converted. There are 10,000,000 shares of Series A outstanding as of October 31, 2014.
	Options
	As of October 31, 2014, there were options issued and outstanding for the purchases of 1,800,000 shares of Common Stock under the 2010 Equity Incentive Plan and 2,500,000 shares of Common Stock under the 2014 Equity Incentive Plan.
	2010 Equity Incentive Plan
	On January 15, 2010, the Board and Stockholders approved and adopted the 2010 Equity Incentive Plan (the “2010 Plan”).
	The 2010 Plan is intended to promote the interests of the Company by attracting and retaining exceptional employees, consultants, directors, officers and independent contractors (collectively referred to as the “Participants”), and enabling such Participants to participate in the long-term growth and financial success of the Company. Under the 2010 Plan, the Company may grant stock options, which are intended to qualify as “incentive stock options” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Incentive Stock Options”), non-qualified stock options (the “Nonqualified Stock Options”), stock appreciation rights (“SARs”) and restricted stock awards (the “Restricted Stock Awards”), which are restricted shares of Common Stock (the Incentive Stock Options, the Nonqualified Stock Options, the SARs and the Restricted Stock Awards are collectively referred to as “Incentive Awards”). Incentive Awards may be granted pursuant to the 2010 Plan for 10 years from the Effective Date.
	From time to time, the Company may issue Incentive Awards pursuant to the 2010 Plan.  Each of the awards will be evidenced by and issued under a written agreement. In accordance with the rules of the plan, the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.
	No options were granted under the 2010 Plan during three months ended October 31, 2014 and October 31, 2013
	At October 31, 2014, 477,778 options remain available for future grant under the 2010 Plan.
	As of October 31, 2014, there were options outstanding under the 2010 Plan to purchase 200,000 shares of Common Stock at a purchase price of $0.20 per share, 250,000 shares of Common Stock at a purchase price of $0.09 per share, 75,000 shares of Common Stock at a purchase price of $0.03 per share, 275,000 shares of Common Stock at a purchase price of $0.16 per share and 1,000,000 shares of Common Stock at a purchase price of $0.24 per share. No options have been exercised since the Plan was created.
	2014 Equity Incentive Plan
	On June 2, 2014, the Board and Stockholders approved and adopted the 2014 Equity Incentive Plan (the “2014 Plan”).
	The 2014 Plan is intended to promote the interests of the Company by attracting and retaining exceptional employees, consultants, directors, officers and independent contractors (collectively referred to as the “Participants”), and enabling such Participants to participate in the long-term growth and financial success of the Company. Under the 2014 Plan, the Company may grant stock options, which are intended to qualify as “incentive stock options” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Incentive Stock Options”), non-qualified stock options (the “Nonqualified Stock Options”), stock appreciation rights (“SARs”) and restricted stock awards (the “Restricted Stock Awards”), which are restricted shares of Common Stock (the Incentive Stock Options, the Nonqualified Stock Options, the SARs and the Restricted Stock Awards are collectively referred to as “Incentive Awards”). Incentive Awards may be granted pursuant to the 2014 Plan for 10 years from the Effective Date.
	From time to time, the Company may issue Incentive Awards pursuant to the 2014 Plan.  Each of the awards will be evidenced by and issued under a written agreement. In accordance with the rules of the plan, the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.
	The Board reserved a total of 10,000,000 shares of Common Stock for issuance under the 2014 Plan. If an incentive award granted under the 2014 Plan expires, terminates, is unexercised or is forfeited, or if any shares are surrendered in connection with an incentive award, the shares subject to such award and the surrendered shares will become available for further awards under the Plan.
	The number of shares subject to the 2014 Plan, any number of shares subject to any numerical limit in the 2014 Plan, and the number of shares and terms of any Incentive Award may be adjusted in the event of any change in the Company outstanding Common Stock by reason of any stock dividend, spin-off, stock split, reverse stock split, recapitalization, reclassification, merger, consolidation, liquidation, business combination or exchange of shares, or similar transaction.
	On August 11, 2014, 1,750,000 options were granted to two employees at an exercise price of $0.24 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 2.48%; volatility of 49%; expected life of 6.5 years; and zero dividend yield, the Company recognized a non-cash stock compensation charge of $27,129 for the three months ended October 31, 2014 in connection with the issuance and vesting of these options.
	On September 5, 2014, 750,000 options were granted to one employee at an exercise price of $0.24 per share. By using the Black-Scholes option pricing model with the following assumptions: risk-free interest rate of 2.48%; volatility of 43%; expected life of 6.5 years; and zero dividend yield, the Company recognized a non-cash stock compensation charge of $5,378 for the three months ended October 31, 2014 in connection with the issuance and vesting of these options.
	As of October 31, 2014, there were options outstanding under the 2014 Plan to purchase 2,500,000 shares of Common Stock at a purchase price of $0.24 per share. No options have been exercised since the Plan was created.
	Common Stock
	In September 2011, the Company amended and restated its Articles of Incorporation to effectuate a 1 for 8 reverse stock split by decreasing the authorized shares for issuance from 1,000,000,000 shares of common stock, $0.001 par value per share to 125,000,000 shares of common stock, $0.008 par value per share. There were 27,542,528 shares and 26,162,093 outstanding as of October 31, 2014 and July 31, 2014, respectively.
	On August 11, 2014, the Company issued 250,000 shares of common stock to its investor relations firm in exchange for service provided.
	On August 11, 2014, the Company issued 200,000 shares of common stock to Mr. Robert Radoff, a member of the Board of Directors as compensation.
	On August 28, 2014, the Company issued 170,000 shares of common stock to certain advisors to the Company in exchange for advisory services provided.
	Kodiak Capital Group LLC Investment Agreement
	On October 31, 2011, we entered into an Investment Agreement and a Registration Rights Agreement with Kodiak Capital Group, LLC (the “Investor”) to purchase up to $1,000,000 of the Company’s Common Stock. In accordance with these Equity Line Transaction agreements, the Company filed a registration statement on Form S-1, which was declared effective on January 25, 2013. The Investment Agreement allows the Company to sell Common Stock in increments of $25,000 at a per share purchase price equal to 80% of the volume weighted average price of the Common Stock over five consecutive trading days. The agreements provide for the Company to exercise put options that obligate the Investor to purchase common stock shares valued at $25,000 per each put option.
	On March 25, 2014, the Company sold 120,193 shares of Common Stock for $25,000 to the Investor. The Company issued the following common stock shares to the Investor, each in exchange for a $25,000 investment; 208,333 shares on May 12, 2014; 100,806 shares on May 27, 2014; 148,810 shares on September 23, 2014; 168,919 shares on October 3, 2014; 219,491 shares on October 13, 2014; and 223,215 shares on October 22, 2014.

Property_and_Equipment

Property and Equipment	3 Months Ended
	Oct. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 8 – Property and Equipment
	Property and equipment are stated at cost. Depreciation is calculated using the straight-line method over the following estimated useful lives of the assets: furniture and fixtures –seven years; machinery and equipment –five years; software – five years; leasehold improvements –the life of the current facility lease. Major additions and betterments are capitalized and repairs and maintenance are charged to operations in the period incurred. Depreciation expense for the three months ended October 31, 2014 and 2013 was $6,421 and $4,134, respectively.
		October 31, 2014		July 31, 2013
	Furniture and fixture	$	27,634	$	27,634
	Machinery and equipment		27,540		27,540
	Software		359,417		359,417
	Leasehold Improvements		5,985		5,985
	Vehicle		105,278		105,278
			525,854		525,854
	Accumulated depreciation		-434,712		-428,291
	Property and equipment, net	$	91,142	$	97,563

Note_Payable_Auto_loan

Note Payable (Auto loan)	3 Months Ended
	Oct. 31, 2014
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Note 9 - Note Payable (Auto loan)
	Note payable consists of the following as of October 31, 2014 and July 31, 2014:
	Note Payable Consists of the Following at:
		October 31, 2014		July 31, 2014
	Note payable (Auto Loan)	$	71,404	$	74,713
	Less current portion		15,688		15,735
	Long-term note payable	$	55,716		58,978
	Note payable, secured by vehicle, bears interest at 3.99% per annum and has a maturity date of October 9, 2019.

Revision_of_Prior_Period_Amoun

Revision of Prior Period Amounts	3 Months Ended
	Oct. 31, 2014
Accounting Changes and Error Corrections [Abstract]
Accounting Changes and Error Corrections [Text Block]	Note 10 – Revision of Prior Period Amounts
	It was determined during the preparation of the interim financial statements for the three months ended October 31, 2014, that adjustments were required relating to periods preceding August 1, 2014. These adjustments resulted from the Company’s re-evaluation of the accounting treatment of the Series B Convertible Redeemable Preferred Stock (the “Series B”), which was originally recorded in stockholders’ equity upon issuance. Management determined that the Series B meets the definition of a temporary equity instrument in accordance with ASC Topic 480-10-S99“Accounting for Redeemable Equity Instruments”. Accordingly, the Company determined that the Series B should be classified as temporary equity and recorded at its redemption value.
	Management has evaluated the effect of this prior period adjustment and determined that it was immaterial to each of the reporting periods affected and, therefore, amendment of previously filed reports was not required. In accordance with guidelines issued in SEC Staff Accounting Bulletin, we have recorded adjustments to correct and reclassify the current year’s beginning Series B and additional paid in capital amounts to correct these immaterial prior period errors. We also plan to revise in future filings of our 10-Q and 10-K, the previously reported quarterly and annual financial statements during the year ended July 31, 2014 for these immaterial amounts.
	The following table sets forth the revised prior period balances reported in our comparative financial statements:
		Previously
		reported	Adjustment	Revised
	Balance sheet items at July 31, 2014:
	Preferred Stock, Series B	2,100	260,375	262,475
	Additional paid in capital	16,777,826	-260,375	16,517,451
	Total stockholders’ equity	5,578,824	-262,475	5,316,349

Subsequent_Events

Subsequent Events	3 Months Ended
	Oct. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	Note 11 – Subsequent Events
	Management of the Company performed an evaluation of all subsequent events that occurred as of the date these financial statements were issued to determine if they must be reported. Management of the Company has determined that the following subsequent events are required to be disclosed:
	On November 20, 2014, the CEO of the Company has converted 10,000,000 shares of preferred A to 20,000,000 shares of common stocks.
	On December 18, 2014, the Company effectuated a Securities Purchase Agreement (the “Agreement”) with an accredited investor (the “Investor”) for the purchase and sale of up to $285,000 of the Company’s original issue discount convertible debentures (collectively, the “Debentures”). The Debentures do not bear interest and are convertible into shares of Common Stock at a conversion price equal to seventy percent (70%) of the lowest closing bid price (as reported by Bloomberg LP) of the Common Stock for the twenty (20) trading days immediately preceding the date of conversion. In addition, the Company paid the Investor a fee consisting of $5,000 and 200,000 shares of restricted Common Stock in connection with the due diligence review of the Company and reimbursed the Investor for $5,000 in legal fees incurred by the Investor. The first Debenture, in the principal amount of $160,000, was issued on December 18, 2014 (the “Closing Date”). An additional Debenture in the principal amount of $125,000 may be issued by the Registrant to the Investor anytime sixty-one (61) days following the Closing Date subject to the satisfaction of the terms and conditions set forth in the Agreement (the “Second Closing”).

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Oct. 31, 2014
Accounting Policies [Abstract]
Segment Reporting, Policy [Policy Text Block]	a) Segment Information - The Company follows ASC Topic 280, “Disclosures about Segments of an Enterprise and Related Information.” Topic 280 requires that a company report financial and descriptive information about its reportable operating segments. Operating segments are components of an enterprise for which separate financial information is available and is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker currently evaluates the Company’s operations from a number of different operational perspectives including but not limited to a client by client basis. The Company derives all significant revenues from a single reportable operating segment of business. Accordingly, the Company does not report more than one segment; nevertheless, management evaluates, at least annually, whether the Company continues to have one single reportable segment.
Use of Estimates, Policy [Policy Text Block]	b) Use of Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates, and the differences may be material to the financial statements. Estimates are used primarily in determining the depreciable lives of fixed assets, valuation of stock based compensation, and inventory valuation. In addition, estimates form the basis for the reserves for sales allowances, accounts receivable and inventory. Various assumptions go into the determination of these estimates. The process of determining significant estimates requires consideration of factors such as historical experience and current and expected economic conditions.
Cash and Cash Equivalents, Policy [Policy Text Block]	c) Cash and Cash Equivalents - The Company considers all highly liquid investments and time deposits with original maturities of three months or less when purchased to be cash equivalents. All cash and cash equivalents are maintained with nationally recognized financial institutions.
Allowance for Doubtful Accounts [Policy Text Block]	d) Allowance for Doubtful Accounts - An allowance for doubtful accounts is computed based on the Company’s historical experience and management’s analysis of possible bad debts. Accounts receivable are shown net of an allowance for doubtful accounts of $166as of October 31, 2014 and $26 as of July 31, 2014, respectively.
Inventory, Policy [Policy Text Block]	e) Inventory - Inventory is stated at the lower of cost or market on an average cost basis. Inventory reserves are recorded for damaged, obsolete, excess and slow-moving inventory. Market value of inventory is estimated based on the impact of market trends, an evaluation of economic conditions and the value of current orders relating to the future sales of this type of inventory. As of October 31, 2014 and July 31, 2014, the value of the inventory reserve was $6,361 and $7,352 respectively, and the majority of the inventory was comprised of finished goods.
Income Tax, Policy [Policy Text Block]	f) Income Taxes - The Company accounts for income taxes pursuant to the FASB ASC Topic 740, "Accounting for Uncertainty in Income Taxes", (“Topic 740”). Topic 740 clarifies the accounting for uncertainty in income taxes recognized in the Company’s financial statements in accordance with generally accepted accounting principles. The calculation of the Company's tax provision involves the application of complex tax rules and regulations within multiple jurisdictions. The Company's tax liabilities include estimates for all income-related taxes that the Company believes are probable and that can be reasonably estimated. To the extent that the Company’s estimates are understated, additional charges to the provision for income taxes would be recorded in the period in which the Company determines such understatement. If the Company's income tax estimates are overstated, income tax benefits will be recognized when realized. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Topic 740 prescribes a recognition threshold and measurement attributes for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	g) Intangible Assets – Developed technology and trade names were acquired as part of the Veloxum transaction in May 2014. Acquisition –related intangibles are amortized over their estimated useful lives based on expected future benefit.
	The carrying amounts of the intangible assets as of October 31, 2014 and July 31, 2014 are as follows:
		Intangible Assets, Gross						Accumulated Amortization						Intangible Assets, Net				Weighted
																		Average Useful
																		Life
		July 31, 2014		Additions		31-Oct-14		31-Jul-14		Expense		October 31, 2014		31-Jul-14		October 31, 2014		(Years)
	Developed technology	$	4,423,375	$	-	$	4,423,375	$	-133,203	$	-157,978	$	-291,181	$	4,290,172	$	4,132,194		7
	Trade names		816,800				816,800		-24,597		-29,171		-53,768		792,203		763,032		7
	Total intangible assets, net	$	5,240,175	$	-	$	5,240,175	$	-157,800	$	-187,149	$	-344,949	$	5,082,375	$	4,895,226
	Total amortization expense related to intangible assets was $187,149 for the three months ended October 31, 2014, all of which was recorded in operating expenses. As of October 31, 2014, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows:
						Total
		Developed		Trade		intangible
	Year ending July 31,	technology		names		assets
	2015	$	473,933	$	87,515	$	561,448
	2016		631,911		116,686		748,597
	2017		631,911		116,686		748,597
	2018		631,911		116,686		748,597
	2019		631,911		116,686		748,597
	Thereafter		1,130,617		208,773		1,339,390
	Total intangible assets subject to amortization		4,132,194	$	763,032	$	4,895,226
	Developed technology and trade name are tested for impairment based on the guidelines in Accounting Standards Codification Topic 360-10-35, Impairment or Disposal of Long-Lived Assets
	A long-lived asset or asset group that is held and used should be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount for the long-live asset or asset group might not be recoverable. As a result, a company is not required to perform an impairment analysis if indicators of impairment are not present. Instead, a company would assess the need for an impairment write-down only if an indicator of impairment (also referred to as a triggering event) is present. As of October 31, 2014, no triggering events have occurred which would indicate that the acquired Veloxum developed technology and trade name values may not be recoverable. The strategy and plans that had been put in place at the original acquisition date were still effective and progressing as planned.
Revenue Recognition, Policy [Policy Text Block]	h) Revenue Recognition - The Company's product revenues are recognized upon shipment or delivery and acceptance of products by customers, when pervasive evidence of a sales arrangement exists, the price is fixed or determinable, the title has transferred and collection of resulting receivables is reasonably assured. For service and development projects, the company recognizes revenue upon the completion of the service and records costs incurred by the company for service and development under the project as cost of sales expenses.
Research and Development Expense, Policy [Policy Text Block]	i) Research and Development Costs -Research and development costs are charged to operations as incurred. Research and development expenses consist primarily of compensation and related costs for personnel responsible for the research and development activities relating to new and existing products.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	j) Stock-Based Compensation - The Company accounts for its stock-based compensation expense based on the fair value of the stock-based awards that are ultimately expected to vest. The fair value of employee stock option grant is estimated on the date of grant using the Black-Scholes option pricing model, and is recognized as expense on a straight-line basis over the employee’s requisite service period (generally the vesting period), net of estimated forfeitures. Forfeitures are estimated at the time of grant and revised in subsequent periods if actual forfeitures differ from the prior estimates.
	The Company records the expense attributed to non-employee services paid with stock-based awards based on the estimated fair value of the awards determined using the Black-Scholes option pricing model. The measurement of stock-based compensation for non-employees is subject to re-measurement as the options vest, and the expense is recognized over the period during which services are received.
Fair Value of Financial Instruments, Policy [Policy Text Block]	k) Fair Value of Financial Instruments -  The Company records its financial assets and liabilities at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value should maximize the use of observable inputs and minimize the use of unobservable inputs. The accounting guidance for fair value establishes a three-level hierarchy for disclosure of fair value measurements, as follows:
	Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.
	Level 2—Inputs (other than quoted market prices included in Level 1) that are either directly or indirectly observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the instrument’s anticipated life.
	Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The carrying values of certain financial assets and liabilities of the Company, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities. The carrying value of the Company’s note payable (Auto loan) approximates its fair value as the terms of the borrowing are consistent with current market rates that the Company could obtain for debt with similar terms and maturities.
Concentration [Policy Text Block]	l) Concentration - Financial instruments which potentially subject the Company to concentrations of credit risk are primarily accounts receivable. The Company performs ongoing credit evaluations of its customers’ financial condition. If the collection of the receivable becomes doubtful, the Company establishes a reserve in an amount determined appropriate for the perceived risk.
	The Company maintains its cash accounts at commercial banks. From time to time, cash balances maintained in such banks may exceed the insured amount by the Federal Deposit Insurance Corporation (FDIC). As of October 31, 2014 and July 31, 2014, management does not believe they are exposed to any significant risk on their cash balances. The Company’s products are primarily sold to global medical device companies. These customers can be significantly affected by changes in economic, competitive or other factors. The Company makes substantial sales to a relatively few, large customers, where company is seeking to capture more business from other targeted medical device companies.
	One customer accounted for $85% of revenue for the three months ended October 31, 2014 and two customers accounted for 92% of revenue for the three months ended October 31, 2013.
	One vendor accounted for 100% of the purchases for the three months ended October 31, 2014, and one vendor accounted for 97% of the purchases for the three months ended October 31, 2013.

Organization_and_Principal_Act1

Organization and Principal Activities (Tables)	3 Months Ended
	Oct. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Subsidiaries Establishment and Incorporation [Table Text Block]	Details of the Company’s subsidiary as of October 31, 2014 are as follows:
	Name	Place and Date of	Relationships	Principal Activities
		Establishment/
		Incorporation
	E-Care USA, Inc.	Nevada	Wholly-owned subsidiary of AmbiCom Holdings, Inc.	Designer and developer of wireless home medical devices
		15-Mar-11

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Oct. 31, 2014
Accounting Policies [Abstract]
Schedule of Intangible Assets and Goodwill [Table Text Block]	The carrying amounts of the intangible assets as of October 31, 2014 and July 31, 2014 are as follows:
		Intangible Assets, Gross						Accumulated Amortization						Intangible Assets, Net				Weighted
																		Average Useful
																		Life
		July 31, 2014		Additions		31-Oct-14		31-Jul-14		Expense		October 31, 2014		31-Jul-14		October 31, 2014		(Years)
	Developed technology	$	4,423,375	$	-	$	4,423,375	$	-133,203	$	-157,978	$	-291,181	$	4,290,172	$	4,132,194		7
	Trade names		816,800				816,800		-24,597		-29,171		-53,768		792,203		763,032		7
	Total intangible assets, net	$	5,240,175	$	-	$	5,240,175	$	-157,800	$	-187,149	$	-344,949	$	5,082,375	$	4,895,226
Finite-lived Intangible Assets Amortization Expense [Table Text Block]	As of October 31, 2014, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows:
						Total
		Developed		Trade		intangible
	Year ending July 31,	technology		names		assets
	2015	$	473,933	$	87,515	$	561,448
	2016		631,911		116,686		748,597
	2017		631,911		116,686		748,597
	2018		631,911		116,686		748,597
	2019		631,911		116,686		748,597
	Thereafter		1,130,617		208,773		1,339,390
	Total intangible assets subject to amortization		4,132,194	$	763,032	$	4,895,226

Property_and_Equipment_Tables

Property and Equipment (Tables)	3 Months Ended
	Oct. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		October 31, 2014		July 31, 2013
	Furniture and fixture	$	27,634	$	27,634
	Machinery and equipment		27,540		27,540
	Software		359,417		359,417
	Leasehold Improvements		5,985		5,985
	Vehicle		105,278		105,278
			525,854		525,854
	Accumulated depreciation		-434,712		-428,291
	Property and equipment, net	$	91,142	$	97,563

Notes_Payable_Auto_loan_Tables

Notes Payable (Auto loan) (Tables)	3 Months Ended
	Oct. 31, 2014
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	Note Payable Consists of the Following at:
		October 31, 2014		July 31, 2014
	Note payable (Auto Loan)	$	71,404	$	74,713
	Less current portion		15,688		15,735
	Long-term note payable	$	55,716		58,978

Revision_of_Prior_Period_Amoun1

Revision of Prior Period Amounts (Tables)	3 Months Ended
	Oct. 31, 2014
Accounting Changes and Error Corrections [Abstract]
Schedule of Quantifying Prior Year Misstatements Corrected in Current Year Financial Statements [Table Text Block]	The following table sets forth the revised prior period balances reported in our comparative financial statements:
		Previously
		reported	Adjustment	Revised
	Balance sheet items at July 31, 2014:
	Preferred Stock, Series B	2,100	260,375	262,475
	Additional paid in capital	16,777,826	-260,375	16,517,451
	Total stockholders’ equity	5,578,824	-262,475	5,316,349

Organization_and_Principal_Act2

Organization and Principal Activities (Details) (E-Care USA, Inc. [Member])	3 Months Ended
	Oct. 31, 2014
E-Care USA, Inc. [Member]
Subsidiaries Establishment And Incorporation [Line Items]
Entity Incorporation, Date of Incorporation	15-Mar-11
Entity Incorporation, State Country Name	Nevada
Relationship Subsidiary	Wholly-owned subsidiary of AmbiCom Holdings, Inc.
Sale of Stock, Nature of Operations	Designer and developer of wireless home medical devices

Organization_and_Principal_Act3

Organization and Principal Activities (Details Textual) (USD $)	0 Months Ended	1 Months Ended
	Jan. 15, 2010	29-May-14	Oct. 31, 2014	Jul. 31, 2014
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Initial Shares Authorized	75,000,000
Shares Authorized After Amendment of Articles of Incorporation	1,050,000,000
Common Stock, Shares Authorized			125,000,000	125,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)			$0.01	$0.01
Stockholders' Equity Note, Stock Split	forward-split such that 131.2335958 shares of Common Stock were issued for every 1 share of Common Stock
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	20,000,000	13,100,437
Business Combination, Options Issued to Acquire Entity Exercise Price (in dollars per share)	$0.01
Business Combination, Warrants Issued to Acquire Entity, Number of Securities Called by Warrants or Rights	500,000
Business Combination, Warrants Issued to Acquire Entity Exercise Price (in dollars per share)	$0.50
Common Stock Price Value Per Share at Closing of the Offering (in dollars per share)	$0.40
Aggregate Common Stock Shares at Closing of Offering	1,250,000
Common Stock Aggregate Offering Price Value (in dollars)	$500,000
Series A Preferred Stock [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Preferred Stock, Shares Authorized			10,000,000	10,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)			$0.00	$0.00
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	2,350,000
Series B Preferred Stock [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	2,600,000
Common Stock [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Common Stock, Shares Authorized	1,000,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)	$0.00
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	5,500,000
Preferred Stock [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Preferred Stock, Shares Authorized	50,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$0.00

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Intangible Assets, Gross	$5,240,175
Intangible Assets, Additions	0
Intangible Assets, Gross	5,240,175
Accumulated Amortization	-157,800
Accumulated Amortization, Expense	-187,149	0
Accumulated Amortization	-344,949
Intangible Assets, Net	5,082,375
Intangible Assets, Net	4,895,226
Developed Technology Rights [Member]
Intangible Assets, Gross	4,423,375
Intangible Assets, Additions	0
Intangible Assets, Gross	4,423,375
Accumulated Amortization	-133,203
Accumulated Amortization, Expense	-157,978
Accumulated Amortization	-291,181
Intangible Assets, Net	4,290,172
Intangible Assets, Net	4,132,194
Weighted Average Useful Life (Years)	7 years
Trade Names [Member]
Intangible Assets, Gross	816,800
Intangible Assets, Additions
Intangible Assets, Gross	816,800
Accumulated Amortization	-24,597
Accumulated Amortization, Expense	-29,171
Accumulated Amortization	-53,768
Intangible Assets, Net	792,203
Intangible Assets, Net	$763,032
Weighted Average Useful Life (Years)	7 years

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details 1) (USD $)	Oct. 31, 2014	Jul. 31, 2014
2015	$561,448
2016	748,597
2017	748,597
2018	748,597
2019	748,597
Thereafter	1,339,390
Total intangible assets subject to amortization	4,895,226	5,082,375
Developed Technology Rights [Member]
2015	473,933
2016	631,911
2017	631,911
2018	631,911
2019	631,911
Thereafter	1,130,617
Total intangible assets subject to amortization	4,132,194	4,290,172
Trade Names [Member]
2015	87,515
2016	116,686
2017	116,686
2018	116,686
2019	116,686
Thereafter	208,773
Total intangible assets subject to amortization	$763,032	$792,203

Summary_of_Significant_Account5

Summary of Significant Accounting Policies (Details Textual) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Jul. 31, 2014
Accounting Policies [Line Items]
Allowance for Doubtful Accounts Receivable, Current (in dollars)	$166		$26
Inventory Valuation Reserves (in dollars)	6,361		7,352
Amortization of Intangible Assets	$187,149	$0
Vendor 1 [Member] | Cost of Goods, Total [Member]
Accounting Policies [Line Items]
Entity Wide Purchase, Major Supplier, Percentage	100.00%
Vendor 2 [Member] | Cost of Goods, Total [Member]
Accounting Policies [Line Items]
Entity Wide Purchase, Major Supplier, Percentage		97.00%
One Customer [Member] | Sales Revenue, Net [Member]
Accounting Policies [Line Items]
Entity Wide Revenue Major Customer Percentage	85.00%
Two Customer [Member] | Sales Revenue, Net [Member]
Accounting Policies [Line Items]
Entity Wide Revenue Major Customer Percentage		92.00%

Liquidity_and_Managements_Plan1

Liquidity and Management's Plan (Details Textual) (USD $)	3 Months Ended		1 Months Ended	0 Months Ended	1 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Oct. 22, 2014	12-May-14	Oct. 13, 2014	Oct. 03, 2014	Sep. 23, 2014	27-May-14	Mar. 25, 2014	Jul. 31, 2014	Jul. 31, 2013	Dec. 18, 2014
Cash and Cash Equivalents, at Carrying Value, Total	$194,345	$537,205								$523,540	$596,871
Accumulated Deficit	12,334,397									11,420,396
Net Loss	914,001	-123,381
Net Cash Used in Operating Activities	425,889	38,617
Kodiak Capital Group LLC Investment Agreement [Member]
Stock Issued During Period, Value, New Issues	25,000		25,000	25,000	25,000	25,000	25,000	25,000	25,000
Investments	1,000,000
Investment Owned, Balance, Principal Amount	175,000
Subsequent Event [Member] | Convertible Debentures [Member]
Debt Instrument, Face Amount												285,000
Subsequent Event [Member] | First Convertible Debentures [Member]
Debt Instrument, Face Amount												$160,000

Commitments_and_Contingencies_

Commitments and Contingencies (Details Textual) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Commitments and Contingencies Disclosure [Line Items]
Rent Expenses	$13,419	$13,419
Lease Expiration Date	31-May-16

Series_B_Convertible_Redeemabl1

Series B Convertible Redeemable Preferred Stock (Details Textual) (Series B Preferred Stock [Member], USD $)	3 Months Ended
	Oct. 31, 2014	Jul. 31, 2014	Sep. 30, 2011
Convertible Redeemable Preferred Stock, Series B [Line Items]
Preferred Stock, Shares Outstanding	262,475	262,475
Preferred Stock, Dividend Rate, Percentage	6.00%
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$1
Stock Conversion Price	$0.40
Weighted Average Price of Common Stock Percentage	70.00%
Preferred Stock, Redemption Price Per Share	$1
Preferred Stock, Liquidation Preference, Value	$2,600,000
Before Amendment [Member]
Convertible Redeemable Preferred Stock, Series B [Line Items]
Preferred Stock, Shares Authorized			2,600,000
Preferred Stock, Par or Stated Value Per Share			$0.00
After Amendment [Member]
Convertible Redeemable Preferred Stock, Series B [Line Items]
Preferred Stock, Shares Authorized			325,000
Preferred Stock, Par or Stated Value Per Share			$0.01

Shareholders_Equity_Details_Te

Shareholders' Equity (Details Textual) (USD $)

3 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

Oct. 31, 2014

Oct. 31, 2013

Oct. 22, 2014

12-May-14

Oct. 13, 2014

Oct. 03, 2014

Sep. 23, 2014

27-May-14

Mar. 25, 2014

Oct. 31, 2011

Jul. 31, 2014

Aug. 28, 2014

Aug. 11, 2014

Sep. 05, 2014

Sep. 30, 2011

Stockholders' Equity Note [Line Items]

Common Stock, Shares, Issued

27,542,528

26,162,093

Common Stock, Shares, Outstanding

27,542,528

26,162,093

Common Stock, Par or Stated Value Per Share (in dollars per share)

$0.01

$0.01

Exercise Price of Options, Description

the exercise price of options granted shall be not less than 110% of the average of the closing price for the 30 days preceding the grant date.

Share-based Compensation (in dollars)

$63,384

$1,560

Proceeds from Issuance of Common Stock

100,000

0

Kodiak Capital Group LLC Investment Agreement [Member]

Stockholders' Equity Note [Line Items]

Maximum Value Of Common Stock To Be Purchased

1,000,000

Common Stock Purchase Price Volume Percentage

80.00%

Proceeds from Issuance of Common Stock

25,000

25,000

Stock Issued During Period, Shares, New Issues

223,215

208,333

219,491

168,919

148,810

100,806

120,193

Stock Issued During Period, Value, New Issues

25,000

25,000

25,000

25,000

25,000

25,000

25,000

25,000

Common Stock [Member]

Stockholders' Equity Note [Line Items]

Common Stock, Shares, Outstanding

27,542,528

26,162,093

Common Stock [Member] | Advisors [Member]

Stockholders' Equity Note [Line Items]

Stock Issued During Period, Shares, Issued for Services

170,000

Common Stock [Member] | Investor Relations Firm [Member]

Stockholders' Equity Note [Line Items]

Stock Issued During Period, Shares, Issued for Services

250,000

Common Stock [Member] | Director [Member]

Stockholders' Equity Note [Line Items]

Stock Issued During Period, Shares, Share-based Compensation, Gross

200,000

Common Stock [Member] | Before Amendment [Member]

Stockholders' Equity Note [Line Items]

Common Stock, Shares, Issued

1,000,000,000

Common Stock, Par or Stated Value Per Share (in dollars per share)

$0.00

Common Stock [Member] | After Amendment [Member]

Stockholders' Equity Note [Line Items]

Common Stock, Shares, Issued

125,000,000

Common Stock, Par or Stated Value Per Share (in dollars per share)

$0.01

Preferred Stock [Member]

Stockholders' Equity Note [Line Items]

Preferred Stock, Shares Authorized

50,000,000

Preferred Stock, Par or Stated Value Per Share (in dollars per share)

$0.00

Series A Preferred Stock [Member]

Stockholders' Equity Note [Line Items]

Preferred Stock, Shares Authorized

10,000,000

10,000,000

Preferred Stock, Shares Outstanding

10,000,000

10,000,000

Preferred Stock, Par or Stated Value Per Share (in dollars per share)

$0.00

$0.00

Equity Incentive Plans 2010 [Member]

Stockholders' Equity Note [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

477,778

Equity Incentive Plans 2010 [Member] | Common Stock Issuance One [Member]

Stockholders' Equity Note [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding

200,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$0.20

Equity Incentive Plans 2010 [Member] | Common Stock Issuance Two [Member]

Stockholders' Equity Note [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding

250,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$0.09

Equity Incentive Plans 2010 [Member] | Common Stock Issuance Three [Member]

Stockholders' Equity Note [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding

75,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$0.03

Equity Incentive Plans 2010 [Member] | Common Stock Issuance Four [Member]

Stockholders' Equity Note [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding

275,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$0.16

Equity Incentive Plans 2010 [Member] | Common Stock Issuance Five [Member]

Stockholders' Equity Note [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding

1,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$0.24

Equity Incentive Plans 2010 [Member] | Common Stock [Member]

Stockholders' Equity Note [Line Items]

Option Outstanding For Purchase

1,800,000

Series A Convertible Preferred Stock [Member]

Stockholders' Equity Note [Line Items]

Preferred Stock, Shares Authorized

10,000,000

Equity Incentive Plans 2014 [Member]

Stockholders' Equity Note [Line Items]

Common Stock, Shares, Issued

10,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding

2,500,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

$0.24

Equity Incentive Plans 2014 [Member] | Two Employees [Member]

Stockholders' Equity Note [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1,750,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

0.24

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

2.48%

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

49.00%

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

6 years 6 months

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

0.00%

Share-based Compensation (in dollars)

27,129

Equity Incentive Plans 2014 [Member] | One Employee [Member]

Stockholders' Equity Note [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

750,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$0.24

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate

2.48%

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

43.00%

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term

6 years 6 months

Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

0.00%

Share-based Compensation (in dollars)

$5,378

Equity Incentive Plans 2014 [Member] | Common Stock [Member]

Stockholders' Equity Note [Line Items]

Option Outstanding For Purchase

2,500,000

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Oct. 31, 2014	Jul. 31, 2014
Property, Plant and Equipment [Line Items]
Furniture and fixture	$27,634	$27,634
Machinery and equipment	27,540	27,540
Software	359,417	359,417
Leasehold Improvements	5,985	5,985
Vehicle	105,278	105,278
Property, Plant and Equipment, Gross	525,854	525,854
Accumulated depreciation	-434,712	-428,291
Property and equipment, net	$91,142	$97,563

Property_and_Equipment_Details1

Property and Equipment (Details Textual) (USD $)	3 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Property, Plant and Equipment [Line Items]
Depreciation	$6,421	$4,134
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	seven years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	five years
Software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	five years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	the life of the current facility lease

Note_Payable_Auto_loan_Details

Note Payable (Auto loan) (Details) (USD $)	Oct. 31, 2014	Jul. 31, 2014
Notes Payable Unsecured Disclosure [Line Items]
Note payable (Auto Loan)	$71,404	$74,713
Less current portion	15,688	15,735
Long-term note payable	$55,716	$58,978

Note_Payable_Auto_loan_Details1

Note Payable (Auto loan) (Details Texual) (Secured Debt [Member], Notes Payable, Other Payables [Member])	3 Months Ended
	Oct. 31, 2014
Secured Debt [Member] | Notes Payable, Other Payables [Member]
Notes Payable Unsecured Disclosure [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	3.99%
Debt Instrument, Maturity Date	9-Oct-19

Revision_of_Prior_Period_Amoun2

Revision of Prior Period Amounts (Details) (USD $)	Oct. 31, 2014	Jul. 31, 2014
Additional paid in capital	$16,853,492	$16,517,451
Total stockholdersb equity	4,749,433	5,316,349
Scenario, Previously Reported [Member]
Preferred Stock, Series B		2,100
Additional paid in capital		16,777,826
Total stockholdersb equity		5,578,824
Restatement Adjustment [Member]
Preferred Stock, Series B		260,375
Additional paid in capital		-260,375
Total stockholdersb equity		-262,475
Redeemable Convertible Preferred Stock [Member]
Preferred Stock, Series B	$262,475	$262,475

Subsequent_Events_Details_Text

Subsequent Events (Details Textual) (Subsequent Event [Member], USD $)	1 Months Ended
	Dec. 18, 2014	Nov. 20, 2014
Investor [Member]
Subsequent Event [Line Items]
Debt Instrument, Fee Amount	$5,000
Convertible Debentures [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount	285,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger	70.00%
First Convertible Debentures [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount	160,000
Second Convertible Debentures [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount	$125,000
Series Preferred Stock [Member]
Subsequent Event [Line Items]
Conversion of Stock, Shares Converted		10,000,000
Common Stock [Member]
Subsequent Event [Line Items]
Conversion of Stock, Shares Issued		20,000,000
Common Stock [Member] | Investor [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Issued for Services	200,000